Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
2055198-07-5 | Sulfo dbco-peg4-maleimide | AA019E5N | MFCD30458040
2112731-95-8 | N-(Azido-PEG3)-N-Boc-PEG4-acid | AA019E9N | MFCD30723226
2183440-30-2 | TCO-PEG4-biotin | AA019EEA | MFCD31561115
2738-05-8 | N,3-Dimethylbutan-2-amine hydrochloride | AA019EHE | MFCD09971391
1168091-15-3 | 2-chloro-6-(hydroxymethyl)-3-Pyridinecarboxylic acid methyl ester | AA019EKU | MFCD17926564
921623-31-6 | 4-(4,4,4-Trifluorobutoxy)benzoic acid | AA019ENW | MFCD25710955
1956319-15-5 | (4-Chloropyridin-3-yl)methanamine hydrochloride | AA019ER5 | MFCD28119158
1427373-22-5 | 4-bromo-2-hydroxy-5-methylbenzaldehyde | AA019EUC | MFCD23705509
616890-33-6 | Cis-Tert-Butyl 2-Allyl-3-Hydroxypiperidine-1-Carboxylate | AA019EXB | MFCD30471970
7413-34-5 | Methotrexate disodium salt | AA019FPF | MFCD00274560